Xifaxa®550mg Tablet

Rifaximin is a broad-spectrum, FDA approved non systemic Gut targeted antibiotic with an excellent safety profile, a lack of drug interactions. Rifaximin acts by inhibition of bacterial RNA synthesis. Rifaximin is bactericidal against a broad array of enteric pathogens, including gram-positive, gram-negative, aerobic and anaerobic bacteria.

Xifaxa (Rifaximin) 550mg tablets are indicated for

  • Hepatic Encephalopathy: for maintenance of Remission of
  • Hepatic encephalopathy.
  • Irritable Bowel Syndrome
  • Traveler’s Diarrhea
  • Surgical Antibiotic Prophylaxis

Xifaxa (Rifaximin) 550mg tablet is available in pack of 10’s tablets.

Make an Inquiry